Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

5,575.00p
   
  • Change Today:
    -175.00p
  • 52 Week High: 6,070.00
  • 52 Week Low: 3,834.00
  • Currency: UK Pounds
  • Shares Issued: 65.77m
  • Volume: 138,674
  • Market Cap: £3,666.45m
  • RiskGrade: 128

Deal with Barclays    Trade now with Barclays Stockbrokers

Regulatory News

Director/PDMR Shareholding 15-Sep-2021 16:45 RNS
Director/PDMR Shareholding 14-Sep-2021 16:32 RNS
Preliminary Results 09-Sep-2021 07:00 RNS
Total Voting Rights 01-Sep-2021 14:05 RNS
Block listing Interim Review 02-Aug-2021 16:00 RNS
Total Voting Rights 02-Aug-2021 10:09 RNS
Total Voting Rights 01-Jul-2021 16:39 RNS
Capital Markets Event & PRRSv Programme Update 22-Jun-2021 07:00 RNS
Notification of Major Holdings 14-Jun-2021 15:01 RNS
Application For Additional Listing 07-Jun-2021 10:42 RNS
Notification of Major Holdings 04-Jun-2021 16:38 RNS
Notification of Major Holdings 17-May-2021 13:23 RNS
Director/PDMR Shareholding 13-May-2021 10:50 RNS
Director/PDMR Shareholding 09-Apr-2021 16:10 RNS
Director/PDMR Shareholding 06-Apr-2021 18:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 5,575.00p
Change Today -175.00p
% Change -3.04 %
52 Week High 6,070.00
52 Week Low 3,834.00
Volume 138,674
Shares Issued 65.77m
Market Cap £3,666.45m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average99.75% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
59.64% above the market average59.64% above the market average59.64% above the market average59.64% above the market average59.64% above the market average
58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average58.06% above the sector average
Income
64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average64.42% below the market average
63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average63.64% below the sector average
Growth
84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average84.16% above the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Nov-21 04-Mar-21
Paid 10-Dec-21 01-Apr-21
Amount 21.70p 10.30p

Trades for 24-Sep-2021

Time Volume / Share Price
16:39 7,975 @ 5,581.97p
16:39 7,675 @ 5,581.97p
16:35 34,631 @ 5,575.00p
16:29 33 @ 5,605.00p
16:29 3 @ 5,600.00p

Genus Key Personnel

CEO Stephen Wilson
CFO Alison Henriksen

Top of Page